Abstract
Purpose
Hematopoietic stem cell transplant (HSCT) is an intense form of treatment, resulting in major symptom burden but can prove curative. The quality of life (QOL) is a major endpoint for these patients as the survival rate in them has improved over time. The aim of the study is to assess the QOL and symptom burden of hematological malignancy patients at admission to hospital for HSCT, at 1 month and at 3 months following HSCT.
Methods
This prospective observational study was done on hematological malignancy patients who were admitted for HSCT in a regional cancer center. The study subjects were assessed by the Functional Assessment of Cancer Therapy–Bone Marrow Transplant Scale (FACT–BMT Scale), Edmonton Symptom Assessment Scale-revised (r-ESAS), and Depression, Anxiety and Stress Scale—21 Items (DASS-21) at the time of hospital admission for transplantation, on day 30 (~ 1 month) and day100 (~ 3 months) of transplantation.
Results
A total of 68 patients were included in this study. FACT–BMT scores have decreased from baseline (F0) to the first follow-up (F1) and then increased in the third follow-up (F2). The maximum r-ESAS mean score was for tiredness among all other symptoms at F0 as well as at F1 and at F2. The DASS 21 scores for depression, anxiety, and stress were maximum during F1 and minimum during F2.
Conclusion
Symptom burden is maximum during the first month of BMT, which improves later and QOL becomes improved with time.
Similar content being viewed by others
References
Das K, Khanna T, Agrawal N (2018) Establishing hematopoietic stem cell transplant unit in resource limited setting: a critical analysis of Indian council of medical research 2017 guidelines. J Transplant 1:2018. https://doi.org/10.1155/2018/1292307
Chaudhry K (2002) Tobacco control in India. In: Agarwal SP, Rao YN and Gupta S (eds) Fifty years of cancer control in India. Directorate General of Health Services, Govt. of India, New Delhi, India, pp 196–211
Bevans MF, Mitchell SA, Marden S (2008) The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). Support Care Cancer 16(11):1243–1254. https://doi.org/10.1007/s00520-008-0420-6
Saikia TK (2020) Blood and bone marrow transplantation in India: past, present, and future. Indian J Med Paediatr Oncol 41(3):308. https://doi.org/10.4103/0971-5851.293846
Naithani R (2018) Hematopoietic stem cell transplantation in India-2017 annual update. Indian J Hematol Blood Transfus 34(1):5–7. https://doi.org/10.1007/s12288-017-0906-9
Bhutani M, Vora A, Kumar L, Kochupillai V (2002) Lympho-hemopoietic malignancies in India. Med Oncol 19(3):141–50. https://doi.org/10.1385/MO:19:3:141
Mukhopadhyay A, Gupta P, Basak J, Chakraborty A, Bhattacharyya D, Mukhopadhyay S, Roy UK (2012) Stem cell transplant: an experience from eastern India. Indian J Med Paediatr Oncol 33(4):203. https://doi.org/10.4103/0971-5851.107078
Hjermstad MJ, Kaasa S (1995) Quality of life in adult cancer patients treated with bone marrow transplantation—a review of the literature. Eur J Cancer 31(2):163–173. https://doi.org/10.1016/0959-8049(94)00464-g
Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM (2000) Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant 6(5):576–591. https://doi.org/10.1016/s1083-8791(00)70067-x
McQuellon RP, Russell GB, Rambo TD, Craven BL, Radford J, Perry JJ, Cruz J, Hurd DD (1998) Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’to recovery over the first year. Bone Marrow Transplant 21(5):477–486. https://doi.org/10.1038/sj.bmt.1701115
El-Jawahri A, Temel JS (2017) Palliative care integration in hematopoietic stem-cell transplantation: the need for additional research. J Oncol Pract 13(9):578–579. https://doi.org/10.1200/JOP.2017.026559
El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, Jackson VA, Telles J, Rhodes A, Spitzer TR, McAfee S (2016) Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA 316(20):2094–2103. https://doi.org/10.1001/jama.2016.16786
Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S (2000) Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 110(3):614–619. https://doi.org/10.1046/j.1365-2141.2000.02053.x
Kiss TL, Abdolell M, Jamal N, Minden MD, Lipton JH, Messner HA (2002) Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol 20(9):2334–2343. https://doi.org/10.1200/JCO.2002.06.077
El-Jawahri AR, Vandusen HB, Traeger LN, Fishbein JN, Keenan T, Gallagher ER, Greer JA, Pirl WF, Jackson VA, Spitzer TR, Chen YB (2016) Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation. Cancer 122(5):806–812. https://doi.org/10.1002/cncr.29818
Marques AD, Szczepanik AP, Machado CA, Santos PN, Guimarães PR, Kalinke LP (2018) Hematopoietic stem cell transplantation and quality of life during the first year of treatment. Rev Latino-Am Enfermagem 26. https://doi.org/10.1590/1518-8345.2474.3065
Shah CA, Karanwal A, Desai M, Pandya M, Shah R, Shah R (2015) Hematopoietic stemcell transplantation in the developing world: experience from a center in Western India. J Oncol 1:2015. https://doi.org/10.1155/2015/710543
Cohen MZ, Rozmus CL, Mendoza TR, Padhye NS, Neumann J, Gning I, Aleman A, Giralt S, Cleeland CS (2012) Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage 44(2):168–180. https://doi.org/10.1016/j.jpainsymman.2011.08.011
Ovayolu O, Ovayolu N, Kaplan E, Pehlivan M, Karadag G (2013) Symptoms and quality of life: before and after stem cell transplantation in cancer. Pak J Med Sci 29(3):803. https://doi.org/10.12669/pjms.293.3290
Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B, Passweg J, Miralbell R, Chalandon Y (2008) Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 42(12):819–827. https://doi.org/10.1038/bmt.2008.253
Garcia CM, Mumby PB, Thilges S, Stiff PJ (2012) Comparison of early quality of life outcomes in autologous and allogeneic transplant patients. Bone Marrow Transplant 47(12):1577–1582. https://doi.org/10.1038/bmt.2012.77
Anderson KO, Giralt SA, Mendoza TR, Brown JO, Neumann JL, Mobley GM, Wang XS, Cleeland CS (2007) Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant 39(12):759–766. https://doi.org/10.1038/sj.bmt.1705664
Chow K, Coyle N (2011) Providing palliative care to family caregivers throughout the bone marrow transplantation trajectory: research and practice: partners in care. J Hosp Palliat Nurs 13(1):7–13. https://doi.org/10.1097/NJH.0b013e3181fce813
Ruiz M, Reynolds P, Marranzini R, Khan A, Ketterer J, Brahim A (2018) Role of early palliative care interventions in hematological malignancies and bone marrow transplant patients: barriers and potential solutions. Am J Hosp Palliat Med® 35(11):1456–60. https://doi.org/10.1177/1049909118772849
Nelson AM, Johnson PC, Kavanaugh AR, Jackson VA, Jagielo AD, Fenech AL, Reynolds MJ, Topping C, Yi AM, Horick N, Temel JS (2021) Palliative care for patients undergoing stem cell transplant: intervention components and supportive care measures. Bone Marrow Transplant 56(8):1971–1977. https://doi.org/10.1038/s41409-021-01281-2
Author information
Authors and Affiliations
Contributions
Neethu Susan Abraham: Detailed literature study, Analysis and synthesis of information, Design of the work, Preparation of manuscript including figures & tables.
Seema Mishra: Revision of draft copy, synthesis of information, critical revision for important intellectual content.
Sushma Bhatnagar, Lalit Kumar, Atul Sharma, Rakesh Garg, Sachidanand Jee Bharati, Nishkarsh Gupta, Vinod Kumar: Overall supervision of the work, critical revision for important intellectual content.
Corresponding author
Ethics declarations
Ethics approval
This study was conducted at Dr B. R. Ambedkar, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. This study was carried out in line with the institutional ethics committee of AIIMS, New Delhi (Ref. No.: IECPG-174/28.02.2019, RT-26/27.03.2019).
Consent to participate
Informed consent was obtained from those participating in the study. All information regarding the subjects was kept confidential.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Abraham, N.S., Mishra, S., Bhatnagar, S. et al. Quality of life and symptom burden in hematological cancer patients receiving hematopoietic stem cell transplantation: an observational study at Regional Cancer Centre, India. Support Care Cancer 32, 274 (2024). https://doi.org/10.1007/s00520-024-08481-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00520-024-08481-8